Cargando…
Targeting cancer stem cells in squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive tumor and the sixth most common cancer worldwide. Current treatment strategies for HNSCC are surgery, radiotherapy, chemotherapy, immunotherapy or combinatorial therapies. However, the overall 5-year survival rate of HNSCC patients...
Autores principales: | Chen, Demeng, Wang, Cun-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770277/ https://www.ncbi.nlm.nih.gov/pubmed/31598386 http://dx.doi.org/10.1093/pcmedi/pbz016 |
Ejemplares similares
-
Generation of a squamous cell carcinoma mouse model for lineage tracing of BMI1+ cancer stem cells
por: Chen, Demeng, et al.
Publicado: (2021) -
Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma
por: Dong, Jiaqiang, et al.
Publicado: (2021) -
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021) -
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
por: Monroe, Marcus M., et al.
Publicado: (2011) -
Cancer stem cells and their niche in the progression of squamous cell carcinoma
por: Oshimori, Naoki
Publicado: (2020)